Pharmacogenetics in Pediatrics

Home
»
2025 National Conference
»
Product Details

You must select a location to proceed.

Yes

There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.

Adding Registration, Please wait...

You must be logged in to perform this action.

Cancel

Pharmacogenetics in Pediatrics

Recorded for 2025 National Conference

Credit(s):

1.02 Contact Hour(s) of CE; 0.51 of which may be applied towards Pharmacology

Program Number:

25067332

Original Program Date:

June 21, 2025

Duration:

1 hour 1 minute

Access:

Available until July 15, 2026

Special Offer

Click here to see Special Offer(s)!

Facebook

E-Mail

Description
Sessions
Credits
Faculty
Materials
Reviews
Dates and Locations

(49)

Read Reviews

Category: 2025 National Conference, Cert Exam Domain - Assessment, Diagnostic Tests ... (show more)

Category: 2025 National Conference, Cert Exam Domain - Assessment, Diagnostic Tests, Genetics/Genomics, Pediatrics, Pharmacology, Recent Additions (show less)

Activity Duration

Content Expires:

July 15, 2026 (11:55 p.m. CT)
CE for this activity will not be available after this date.

This CE activity was recorded for the 2025 AANP National Conference.

This activity includes closed captioning.

Delivery Note: The content for this activity was previously presented during the 2025 AANP National Conference. If you already completed the content of this activity while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies.

Overview
Pharmacogenetics is the impact of genetic variants on an individual's response to medications or pharmacologic agents. In some situations, genetics dictate pharmacologic interventions, as there are medications that target the pathology of genetic diseases. Examples of this include CFTR-modifying drugs for Cystic Fibrosis or ion channel-modifying drugs for specific forms of genetic epilepsy. In contrast, individuals with the same disease, with or without a genetic component, may respond differently to medications due to their genetics. Different polymorphisms, or variants in specific genes, can impact an individual's response to specific medications, leading to toxicities or lack of therapeutic responses. Genetic testing can provide another data point in the pharmacologic management of a patient. We will provide examples of patient cases to illustrate these concepts.

Objectives

Identify principles of pharmacogenetics.
Reviewing testing for genetic variants.
Discuss pharmacogenetics in the care of pediatric patients with mental health disorders, pain, clotting disorders, cystic fibrosis, and epilepsy.

Speaker
Jennifer L. Hamilton, DNP, APRN, CPNP-PC, PMHS

Disclosure
This program was planned in accordance with AANP CE Standards and Policies.

The speaker has the following disclosures:

I have nothing to disclose related to this presentation.

Disclaimer
Individuals who have contributed to the CE Center (content originally from the 2025 AANP National Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

CE Credit Instructions

Read this activity description, including objectives and disclosures.
Complete all educational content:
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
  - A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
  - A copy of the certificate will be automatically added to your AANP CE Tracker.

Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.

1.02 Contact Hour(s) of CE,
0.51 of which may be applied towards Pharmacology